Requirements for PKC-augmented JNK activation by MKK4/7

Pablo Lopez-Bergami1, Ze'ev Ronai

  • 1Signal Transduction Program, The Burnham Institute for Medical Research, 10901 N. Torrey Pines Road, La Jolla, CA 92037, USA.

Insights

Protein kinase C (PKC) enhances c-Jun N-terminal kinase (JNK) activation by MKK4/7. PKC phosphorylation must precede MKK4/7 action for optimal JNK activity, impacting UV-induced apoptosis.

Area of Science:

  • Cellular signaling pathways
  • Stress response mechanisms
  • Kinase regulation

Background:

  • c-Jun N-terminal kinases (JNKs) are crucial mediators of cellular responses to stress, DNA damage, and cytokines.
  • JNK activation is primarily regulated by upstream kinases MKK4 and MKK7.
  • Previous work indicated protein kinase C (PKC) can augment JNK activation, requiring the adaptor protein RACK1.

Purpose of the Study:

  • To elucidate the specific conditions required for protein kinase C (PKC)-dependent activation of c-Jun N-terminal kinases (JNKs).
  • To understand the temporal relationship between PKC phosphorylation and upstream kinase (MKK4/7) phosphorylation in JNK activation.
  • To investigate the functional consequences of inhibiting PKC-mediated JNK phosphorylation on UV-induced signaling and apoptosis.

Main Methods:

  • In vitro kinase assays to assess JNK phosphorylation and activation by PKC and MKK4/7.
  • Experimental manipulation of the order of kinase phosphorylation events (PKC vs. MKK4/7).
  • UV-irradiation of cells followed by analysis of JNK activation phases and apoptotic responses, with and without PKC inhibition.

Main Results:

  • PKC phosphorylation of JNK alone is insufficient for activation; it augments activation by MKK4 or MKK7.
  • For enhanced JNK activity, PKC phosphorylation of JNK must occur before phosphorylation by MKK4/7.
  • Inhibition of PKC phosphorylation of JNK impaired both early and late phases of UV-induced JNK activation and reduced JNK-mediated apoptosis.

Conclusions:

  • PKC-dependent phosphorylation of JNK is a critical regulatory step that potentiates JNK activation by canonical upstream kinases.
  • The timing of PKC phosphorylation relative to MKK4/7 phosphorylation is essential for maximal JNK activity.
  • These findings reveal key requirements for PKC in modulating JNK signaling pathways, influencing cellular responses to stress like UV irradiation and subsequent apoptosis.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...